PDCO minutes of the 25-28 June 2024 meeting
Submitted by Anonymous (not verified) on 2 September 2024 - 15:31
PDCO minutes of the 25-28 June 2024 meeting
Agenda of the PRAC meeting 2-5 September 2024
Submitted by Anonymous (not verified) on 2 September 2024 - 15:27
Agenda of the PRAC meeting 2-5 September 2024
Amoxicillin and amoxicillin/clavulanic acid supply shortage
Submitted by Anonymous (not verified) on 2 September 2024 - 14:45
Amoxicillin and amoxicillin/clavulanic acid supply shortage
Human medicines European public assessment report (EPAR): Toujeo (previously Optisulin), insulin glargine, Date of authorisation: 26/06/2000, Revision: 36, Status: Authorised
Submitted by Anonymous (not verified) on 2 September 2024 - 14:45
Human medicines European public assessment report (EPAR): Toujeo (previously Optisulin), insulin glargine, Date of authorisation: 26/06/2000, Revision: 36, Status: Authorised
Human medicines European public assessment report (EPAR): Saphnelo, anifrolumab, Date of authorisation: 14/02/2022, Revision: 7, Status: Authorised
Submitted by Anonymous (not verified) on 30 August 2024 - 14:40
Human medicines European public assessment report (EPAR): Saphnelo, anifrolumab, Date of authorisation: 14/02/2022, Revision: 7, Status: Authorised
Human medicines European public assessment report (EPAR): Azacitidine Kabi, azacitidine, Date of authorisation: 05/01/2024, Revision: 1, Status: Authorised
Submitted by Anonymous (not verified) on 30 August 2024 - 14:29
Human medicines European public assessment report (EPAR): Azacitidine Kabi, azacitidine, Date of authorisation: 05/01/2024, Revision: 1, Status: Authorised
Human medicines European public assessment report (EPAR): Tevagrastim, filgrastim, Date of authorisation: 15/09/2008, Revision: 19, Status: Authorised
Submitted by Anonymous (not verified) on 30 August 2024 - 14:24
Human medicines European public assessment report (EPAR): Tevagrastim, filgrastim, Date of authorisation: 15/09/2008, Revision: 19, Status: Authorised
Human medicines European public assessment report (EPAR): Ratiograstim, filgrastim, Date of authorisation: 15/09/2008, Revision: 17, Status: Authorised
Submitted by Anonymous (not verified) on 30 August 2024 - 14:05
Human medicines European public assessment report (EPAR): Ratiograstim, filgrastim, Date of authorisation: 15/09/2008, Revision: 17, Status: Authorised
Human medicines European public assessment report (EPAR): Revatio, sildenafil, Date of authorisation: 28/10/2005, Revision: 53, Status: Authorised
Submitted by Anonymous (not verified) on 30 August 2024 - 13:40
Human medicines European public assessment report (EPAR): Revatio, sildenafil, Date of authorisation: 28/10/2005, Revision: 53, Status: Authorised
Human medicines European public assessment report (EPAR): Iasibon, ibandronic acid, Date of authorisation: 21/01/2011, Revision: 13, Status: Authorised
Submitted by Anonymous (not verified) on 30 August 2024 - 13:02
Human medicines European public assessment report (EPAR): Iasibon, ibandronic acid, Date of authorisation: 21/01/2011, Revision: 13, Status: Authorised